Genesis Healthcare, Inc.
GENN · OTC
9/30/2021 | 6/30/2021 | 3/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $769,943 | $811,691 | $898,607 | $919,061 |
| % Growth | -5.1% | -9.7% | -2.2% | – |
| Cost of Goods Sold | $748,654 | $756,391 | $929,408 | $523,714 |
| Gross Profit | $21,289 | $55,300 | -$30,801 | $395,347 |
| % Margin | 2.8% | 6.8% | -3.4% | 43% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $136,176 |
| SG&A Expenses | $35,271 | $42,197 | $44,540 | $136,176 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $326,808 |
| Operating Expenses | $35,271 | $42,197 | $44,540 | $462,984 |
| Operating Income | -$13,982 | $13,103 | -$75,341 | -$67,637 |
| % Margin | -1.8% | 1.6% | -8.4% | -7.4% |
| Other Income/Exp. Net | $93,881 | $89,430 | $25,855 | $48,285 |
| Pre-Tax Income | $79,899 | $102,533 | -$49,486 | -$19,352 |
| Tax Expense | $85 | $334 | $458 | -$2,550 |
| Net Income | $57,004 | $71,597 | -$32,449 | -$7,673 |
| % Margin | 7.4% | 8.8% | -3.6% | -0.8% |
| EPS | 0.47 | 0.6 | -0.28 | -0.15 |
| % Growth | -21.7% | 314.3% | -86.7% | – |
| EPS Diluted | 0.33 | 0.42 | -0.28 | -0.15 |
| Weighted Avg Shares Out | 120,650 | 118,633 | 113,998 | 111,851 |
| Weighted Avg Shares Out Dil | 171,663 | 169,646 | 113,998 | 113,288 |
| Supplemental Information | – | – | – | – |
| Interest Income | $924 | $808 | $937 | $0 |
| Interest Expense | $29,433 | $32,316 | $33,286 | $33,374 |
| Depreciation & Amortization | $40,889 | $62,593 | $67,748 | $23,656 |
| EBITDA | $150,221 | $197,442 | $51,548 | $37,678 |
| % Margin | 19.5% | 24.3% | 5.7% | 4.1% |